| 0 |
Endoglycosidase [EPC] |
1 |
0.0005 |
| 1 |
Type I Interferon Receptor Antagonist [EPC] |
1 |
0.0005 |
| 2 |
Phosphodiesterase 3 Inhibitor [EPC] |
2 |
0.0003 |
| 3 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
1 |
0.0001 |
| 4 |
Asparagine-specific Enzyme [EPC] |
1 |
0.0001 |
| 5 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1 |
0.0000 |
| 6 |
Sulfonylurea [EPC] |
3 |
0.0000 |
| 7 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
1 |
0.0000 |
| 8 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 9 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1 |
0.0000 |
| 10 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 11 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 12 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 13 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 14 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 15 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 16 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 17 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 18 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 19 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 20 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 22 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 24 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 25 |
Loop Diuretic [EPC] |
1 |
0.0000 |
| 26 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Corticosteroid [EPC] |
1 |
0.0000 |